
Kelly McCann, MD, PhD
@drkemccann
Translational breast medical oncologist @UCLA
ID: 1063871047
05-01-2013 19:56:38
75 Tweet
238 Followers
162 Following


📣 Agenda Spotlight: Women’s Cancers Are ADCs best used sequentially, or does the benefit stop after the first? Experts, including Kelly McCann, MD, PhD, will break it down at Great Debates in Solid Tumors. Join the conversation: hubs.ly/Q034KV9x0 #GDST25 #MedicalEducation




Countdown begins! Only a few weeks left until the OncLive #WomenInOncology event. Connect with inspiring leaders, share challenges, and celebrate the power of women in cancer medicine. Kelly McCann, MD, PhD Victoria Rizk, MD Reshma Mahtani Reshma Jagsi Register: ow.ly/lySE50URrZ0


We’re proud to work with these outstanding faculty from Sarah Cannon Docs at Great Debates in Solid Tumors! Join Co-Chairs Erika Hamilton, MD, MD and DrKatyMoore, MD, MS, and experts Andrew McKenzie, PhD, and Vivek Subbiah, MD, MD, as they lead essential discussions on the latest


Join us in Miami Beach for the OncLive #WomenInOncology event on March 6th. Let's raise a glass to the phenomenal women driving progress in cancer medicine. See you there! Kelly McCann, MD, PhD Victoria Rizk, MD Reshma Mahtani Reshma Jagsi Register: ow.ly/YrGY50URs3K


Just a few more days until the OncLive #WomenInOncology event lights up Miami Beach. Get ready to mingle, learn, and be inspired by the brilliance of women in cancer care. Kelly McCann, MD, PhD Victoria Rizk, MD Reshma Mahtani Reshma Jagsi Register: ow.ly/Aayj50URsa8


PI3K Pathway Insights in HR+ MBC Drs. Seth Wander & Kelly McCann, MD, PhD dive into PIK3CA testing and targeted therapies for HR+ metastatic breast cancer, alongside Drs. Megan Kruse & Janice Lu. đź”— bit.ly/3QOPlrD Want more from Drs. Wander & McCann? Catch them at #GDST25:




Mentorship, Advocacy, and Work-Life Balance Are Key to Supporting Women in Oncology Kelly McCann, MD, PhD UCLA Jonsson Comprehensive Cancer Center #WomeninOncology #Oncology onclive.com/view/mentorshi…



Massimo Di Maio Paolo Tarantino Angie DeMichele, MD, MSCE, FASCO ASCO NEJM I have to agree with you, I’m very surprised this was a plenary instead of ASCENT 04. ASCENT 04 is practice changing. SERENA6 is not. #ASCO25



Had a wonderful time at #BridgingTheGaps with Jason A. Mouabbi MD and other brilliant faculty discussing how to optimally incorporate new datasets into practice. Thanks to Komal Jhaveri & Kevin Kalinsky, MD, MS, FASCO for co-chairing a fantastic event, and as always to OncLive.com for hosting!


🎥 Check out our discussion on key updates from #ASCO25 in HR+ #MBC! Thank you to OncLive.com for inviting me on the show! Rebecca Shatsky, MD Rita Nanda Kelly McCann, MD, PhD 📺 Watch the episodes here: onclive.com/peer-exchange/… #ASCO25 #breastcancer